These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
99 related articles for article (PubMed ID: 10215212)
21. Contact, coagulation and platelet interaction with heparin treated equipment during heart surgery. van der Kamp KW; van Oeveren W Int J Artif Organs; 1993 Dec; 16(12):836-42. PubMed ID: 8175200 [TBL] [Abstract][Full Text] [Related]
22. Thrombin generation as an acute effect of cigarette smoking. Kimura S; Nishinaga M; Ozawa T; Shimada K Am Heart J; 1994 Jul; 128(1):7-11. PubMed ID: 8017287 [TBL] [Abstract][Full Text] [Related]
23. Fibrinolysis, antithrombin III, and protein C in neonates during cardiac operations. Petăjă J; Peltola K; Sairanen H; Leijala M; Kekomäki R; Vahtera E; Siimes MA J Thorac Cardiovasc Surg; 1996 Sep; 112(3):665-71. PubMed ID: 8800154 [TBL] [Abstract][Full Text] [Related]
24. Coagulofibrinolysis during heparin-coated cardiopulmonary bypass with reduced heparinization. Kumano H; Suehiro S; Hattori K; Shibata T; Sasaki Y; Hosono M; Kinoshita H Ann Thorac Surg; 1999 Oct; 68(4):1252-6. PubMed ID: 10543488 [TBL] [Abstract][Full Text] [Related]
25. Activation of fibrinolysis in the pericardial cavity during cardiopulmonary bypass. Tabuchi N; de Haan J; Boonstra PW; van Oeveren W J Thorac Cardiovasc Surg; 1993 Nov; 106(5):828-33. PubMed ID: 8231204 [TBL] [Abstract][Full Text] [Related]
26. Activation of coagulation and fibrinolysis during cardiothoracic operations. Hunt BJ; Parratt RN; Segal HC; Sheikh S; Kallis P; Yacoub M Ann Thorac Surg; 1998 Mar; 65(3):712-8. PubMed ID: 9527200 [TBL] [Abstract][Full Text] [Related]
27. Effect of anticoagulation protocol on outcome in patients undergoing CABG with heparin-bonded cardiopulmonary bypass circuits. Aldea GS; O'Gara P; Shapira OM; Treanor P; Osman A; Patalis E; Arkin C; Diamond R; Babikian V; Lazar HL; Shemin RJ Ann Thorac Surg; 1998 Feb; 65(2):425-33. PubMed ID: 9485240 [TBL] [Abstract][Full Text] [Related]
28. Nafamostat mesilate reduces blood cell adhesion to cardiopulmonary bypass circuits: an in-vitro study. Hiroura M; Usui A; Kawamura M; Hibi M; Iwase J J Extra Corpor Technol; 1994 Sep; 26(3):121-5. PubMed ID: 10150679 [TBL] [Abstract][Full Text] [Related]
29. Decreased platelet number and function and increased fibrinolysis contribute to postoperative bleeding in cardiopulmonary bypass patients. Holloway DS; Summaria L; Sandesara J; Vagher JP; Alexander JC; Caprini JA Thromb Haemost; 1988 Feb; 59(1):62-7. PubMed ID: 2452492 [TBL] [Abstract][Full Text] [Related]
31. Comparison of three oxygenator-coated and one total-circuit-coated extracorporeal devices. Baksaas ST; Videm V; Pedersen T; Karlsen H; Mollnes TE; Brosstad F; Svennevig JL Perfusion; 1999 Mar; 14(2):119-27. PubMed ID: 10338323 [TBL] [Abstract][Full Text] [Related]
32. A comparative evaluation of the effect of pump type and heparin-coated surfaces on platelets during cardiopulmonary bypass. Misoph M; Babin-Ebell J; Schwender S Thorac Cardiovasc Surg; 1997 Dec; 45(6):302-6. PubMed ID: 9477463 [TBL] [Abstract][Full Text] [Related]
33. SMA circuits reduce platelet consumption and platelet factor release during cardiac surgery. Defraigne JO; Pincemail J; Dekoster G; Larbuisson R; Dujardin M; Blaffart F; David JL; Limet R Ann Thorac Surg; 2000 Dec; 70(6):2075-81. PubMed ID: 11156123 [TBL] [Abstract][Full Text] [Related]